[IS-TH-79] SOE Session: Retinoblastoma: Intra-Arterial or Intra-Vitreal Chemotherapy (or Perhaps Not at All)?
- Apr 03 (Thu)
- 08:30 - 10:00
- Room 27 - Imperial Hotel 3F Mai
- Chair）Stefan Seregard、Chair）Akihiro Kaneko、Chair）Carol Shields
- Retinoblastoma is the most common primary intraocular malignancy in childhood. During the last few decades, management of this disease has dramatically changed and chemotherapy has emerged as first-line treatment. This is a major change of concept as chemotherapy once used to be the last line of resort. Chemotherapeutic drugs may now be delivered not only systemically, but also selectively into the ophthalmic artery or even directly into the vitreous cavity. The pros and cons of these routes and current indications will be discussed.